Search

Your search keyword '"Pasi A Jänne"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Pasi A Jänne" Remove constraint Author: "Pasi A Jänne" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
16 results on '"Pasi A Jänne"'

Search Results

1. Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC

2. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.

4. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.

5. Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer

6. Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

7. KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

8. Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors

9. Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors

10. Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations

11. Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study

12. An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancerResearch in context

13. Efficacy of Taletrectinib (AB-106/DS-6051b) in ROS1+ NSCLC: An Updated Pooled Analysis of U.S. and Japan Phase 1 Studies

14. Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas

15. Rapamycin Prevents the Development and Progression of Mutant Epidermal Growth Factor Receptor Lung Tumors with the Acquired Resistance Mutation T790M

Catalog

Books, media, physical & digital resources